Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Mechanism of Systemic Iron Regulation and Hematocrit Control By Hepcidin Peptidomimetics in Pre-Clinical Models

Roopa Taranath, PhD, Larry Mattheakis, PhD, Li Zhao, MD PhD, Larry Lee, James Tovera, Jingsong Zhao, PhD, Xiaoli Cheng, PhD, David Liu, PhD

Blood (2020) 136 (Supplement 1): 49–50.

https://doi.org/10.1182/blood-2020-141670

Published: 2020

Journal Articles

CLL-1, a Receptor Expressed on Myeloid Leukemic Stem Cells, Is a Potential Target for Immunotherapy of AML

Wouter Korver, PhD, Xiaoxian Zhao, Shweta Singh, Cecile Pardoux, Jingsong Zhao, Siddhartha Sen, Monica L. Guzman, PhD, Craig T. Jordan, PhD, Eric D Hsi, MD, Arie Abo

Blood (2008) 112 (11): 4003.

https://doi.org/10.1182/blood.V112.11.4003.4003

Published: 2008

Journal Articles

Potent Anti-Cancer Activity of Anti-NTB-a Monoclonal Antibodies in Preclinical Leukemia and Lymphoma Models

Wouter Korver, PhD, Xiaoxian Zhao, Shweta Singh, Cecile Pardoux, Ishita Barman, Gerard Aguilar, Jingsong Zhao, Eric Hsi, MD, Arie Abo

Blood (2008) 112 (11): 4975.

https://doi.org/10.1182/blood.V112.11.4975.4975

Published: 2008

Journal Articles

rNAPc2, a Novel Inhibitor of Tissue Factor/Factor VIIa Complex, Inhibits Tumor Growth and Metastasis in Mouse Models of Colorectal Cancer.

Jingsong Zhao, PhD, Gerard Aguilar, BS, Michael Imperiale, MD, Walter Funk, PhD, Arie Abo, PhD

Blood (2007) 110 (11): 923.

https://doi.org/10.1182/blood.V110.11.923.923

Published: 2007

Journal Articles

rNAPc2, a Novel Inhibitor of Tissue Factor/Factor VIIa Complex, Suppresses Lung Metastasis and Synergizes with 5-FU or Bevacizumab in Mouse Models of Colorectal Cancer.

Jingsong Zhao, PhD, Gerard Aguilar, Steven R. Deitcher, MD, Walter Funk, PhD, Arie Abo, PhD

Blood (2006) 108 (11): 904.

https://doi.org/10.1182/blood.V108.11.904.904

Published: 2006

NARROW

Mechanism of Systemic Iron Regulation and Hematocrit Control By Hepcidin Peptidomimetics in Pre-Clinical Models

CLL-1, a Receptor Expressed on Myeloid Leukemic Stem Cells, Is a Potential Target for Immunotherapy of AML

Potent Anti-Cancer Activity of Anti-NTB-a Monoclonal Antibodies in Preclinical Leukemia and Lymphoma Models

rNAPc2, a Novel Inhibitor of Tissue Factor/Factor VIIa Complex, Inhibits Tumor Growth and Metastasis in Mouse Models of Colorectal Cancer.

rNAPc2, a Novel Inhibitor of Tissue Factor/Factor VIIa Complex, Suppresses Lung Metastasis and Synergizes with 5-FU or Bevacizumab in Mouse Models of Colorectal Cancer.

Email alerts

ASH Publications

American Society of Hematology

Mechanism of Systemic Iron Regulation and Hematocrit Control By Hepcidin Peptidomimetics in Pre-Clinical Models

CLL-1, a Receptor Expressed on Myeloid Leukemic Stem Cells, Is a Potential Target for Immunotherapy of AML

Potent Anti-Cancer Activity of Anti-NTB-a Monoclonal Antibodies in Preclinical Leukemia and Lymphoma Models

rNAPc2, a Novel Inhibitor of Tissue Factor/Factor VIIa Complex, Inhibits Tumor Growth and Metastasis in Mouse Models of Colorectal Cancer.

rNAPc2, a Novel Inhibitor of Tissue Factor/Factor VIIa Complex, Suppresses Lung Metastasis and Synergizes with 5-FU or Bevacizumab in Mouse Models of Colorectal Cancer.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only